Tonix Pharmaceuticals Holding (TNXP) Raw Materials (2023 - 2025)

Tonix Pharmaceuticals Holding's Raw Materials history runs 3 years deep, the most recent figure standing at $2.5 million for Q4 2025.

• On a quarterly basis, Raw Materials fell 18.4% year-over-year to $2.5 million in Q4 2025; TTM through Dec 2025 was $2.5 million, a 18.4% decrease from a year earlier, with the FY2025 full-year figure at $2.5 million, down 18.4% from the prior year.
• Raw Materials rose to $2.5 million in Q4 2025 per TNXP's latest filing, from $2.5 million in the prior quarter.
• Across five years, Raw Materials topped out at $3.6 million in Q4 2023 and bottomed at $2.3 million in Q2 2025.
• The 3-year median for Raw Materials is $2.7 million (2025), against an average of $2.9 million.
• Across the five-year window, Raw Materials retreated 14.95% in 2024 and fell 25.82% in 2025, its largest moves.
• Year by year, Raw Materials stood at $3.6 million in 2023, then retreated by 14.95% to $3.1 million in 2024, then fell by 18.4% to $2.5 million in 2025.
• Per Business Quant, the three latest TNXP Raw Materials figures stand at $2.5 million (Q4 2025), $2.5 million (Q3 2025), and $2.3 million (Q2 2025).